NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE110205 Query DataSets for GSE110205
Status Public on Mar 12, 2019
Title Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Pulmonary sarcomatoid carcinomas (PSCs) are rare and aggressive histological types of non-small cell lung cancer (NSCLC) with a median overall survival of about 9-12 months. In detail, PSCs comprise five different histological subtypes: pleomorphic carcinoma (PLC), giant cell carcinoma (GCC), spindle cell carcinoma (SCC), carcinosarcoma (CS) and pulmonary blastoma (PB). Preoperative pathological diagnosis may fail to identify these tumors and therapeutic options are still limited. PSCs have been scarcely characterized from a molecular point of view because of their rarity, and to date no specific markers have been found for PSCs in comparison with other NSCLC types. In this study a highly sensitive amplicon based whole transcriptome quantification analysis was performed, using the Ion AmpliSeq Transcriptome Human Gene Expression Kit (Life Technologies) on a selected series of 14 PSCs (1 PB, 4 CS, 2 SCC, 2 GCC, 5 PLC) and 3 samples of normal lung parenchyma. PSCs expression data were then compared with transcriptome data of lung adenocarcinoma and squamous cell carcinoma available on The Cancer Genome Atlas database. Thirty-eight genes specifically deregulated in PSC samples were identified. Among these, IGJ and SLMAP were validated by immunohistochemistry on an independent cohort (30 PSCs, 31 lung adenocarcinoma and 31 squamous cell carcinoma cases). Furthermore, a pathway enrichment analysis, performed on differentially expressed genes, revealed that FOXO signalling and Fanconi Anemia pathways, playing a pivotal role in cancer development and progression, are enriched in PSC tumors. The description of peculiar molecular profiles besides increasing our knowledge on PSCs biology may suggest new diagnostic and therapeutic strategies.
 
Overall design Whole transcriptome targeted gene quantification analysis was perfomed on a selected series of 14 pulmonary sarcomatoid carcinomas (1 pulmonary blastoma, 4 carcinosarcomas, 2 spindle cell carcinomas, 2 giant cell carcinomas, 5 pleomorphic carcinomas) and 3 samples of normal lung parenchyma, using the Ion AmpliSeq Transcriptome Human Gene Expression Kit ( Life Technologies).
 
Contributor(s) Alì G, Bruno R, Poma AM, Affinito O, Monticelli A, Piaggi P, Ricciardi S, Lucchi M, Melfi F, Cocozza S, Fontanini G
Citation(s) 30837581
Submission date Feb 06, 2018
Last update date Mar 12, 2019
Contact name Gabriella Fontanini
E-mail(s) gabriella.fontanini@med.unipi.it
Phone +39 050-993260
Organization name University of Pisa
Department Department of Surgical, Medical, Molecular Pathology and Critical Area
Street address Via Roma 57
City Pisa
State/province Italy
ZIP/Postal code 56126
Country Italy
 
Platforms (1)
GPL17303 Ion Torrent Proton (Homo sapiens)
Samples (17)
GSM2982206 IonXpress_002
GSM2982207 IonXpress_003
GSM2982208 IonXpress_004
Relations
BioProject PRJNA433178
SRA SRP132285

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE110205_normalized_data.rpm.bcmatrix.txt.gz 961.7 Kb (ftp)(http) TXT
GSE110205_raw_counts.bcmatrix.txt.gz 601.8 Kb (ftp)(http) TXT
GSE110205_samples.bc_summary.txt.gz 427 b (ftp)(http) TXT
SRA Run SelectorHelp
Processed data are available on Series record
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap